Dr. Hirotsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford University School of MedicineClass of 2017
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to...Emily S Ruiz, Karina Brito, Emily E Karn, R'ay Fodor, Allison T Vidimos
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma.Nina A Ran, Emily E Granger, David G Brodland, Javier Cañueto, David R Carr
JAMA Dermatology. 2025-03-19 - 5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment response.Christine P Lin, Nour Kibbi, Tarek Bandali, Kelsey Hirotsu, Sumaira Z Aasi
Journal of the American Academy of Dermatology. 2025-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: